The Chairman and CEO both participated in the recent $3M private placement @ 26c. This is a good show of confidence, the directors have a lot of skin in the game.
Looking forward to the commencement of the Progenza clinical trials.
RGS Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held